Lynk Pharmaceuticals
- Website
- lynkpharma.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series CSep 2023
- Rounds
- 2
About
Lynk Pharmaceuticals develops small-molecule medicines for autoimmune and inflammatory diseases, targeting unmet clinical needs with differentiated therapies.
Summary
Lynk Pharmaceuticals is a Biotech company. It has raised $50.0M in total across 2 rounds, most recently a $50.0M Series C round in Sep 2023. Investors include Lilly Asia Ventures, New Alliance Capital and TaiLong Capital.
Funding History
Sep 2023
Sign up to see all 2 rounds
Series B through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lynk-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/lynk-pharmaceuticals" alt="Lynk Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>